1. Home
  2. TMDX vs LIVN Comparison

TMDX vs LIVN Comparison

Compare TMDX & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • LIVN
  • Stock Information
  • Founded
  • TMDX 1998
  • LIVN 1987
  • Country
  • TMDX United States
  • LIVN United Kingdom
  • Employees
  • TMDX N/A
  • LIVN N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • TMDX Health Care
  • LIVN Health Care
  • Exchange
  • TMDX Nasdaq
  • LIVN Nasdaq
  • Market Cap
  • TMDX 2.3B
  • LIVN 2.1B
  • IPO Year
  • TMDX 2019
  • LIVN 1993
  • Fundamental
  • Price
  • TMDX $111.50
  • LIVN $44.06
  • Analyst Decision
  • TMDX Buy
  • LIVN Buy
  • Analyst Count
  • TMDX 10
  • LIVN 7
  • Target Price
  • TMDX $122.89
  • LIVN $58.57
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • LIVN 882.2K
  • Earning Date
  • TMDX 05-08-2025
  • LIVN 05-07-2025
  • Dividend Yield
  • TMDX N/A
  • LIVN N/A
  • EPS Growth
  • TMDX N/A
  • LIVN N/A
  • EPS
  • TMDX 1.41
  • LIVN N/A
  • Revenue
  • TMDX $488,227,000.00
  • LIVN $1,275,380,000.00
  • Revenue This Year
  • TMDX $25.33
  • LIVN $5.79
  • Revenue Next Year
  • TMDX $20.53
  • LIVN $5.51
  • P/E Ratio
  • TMDX $79.36
  • LIVN N/A
  • Revenue Growth
  • TMDX 64.43
  • LIVN 7.62
  • 52 Week Low
  • TMDX $55.00
  • LIVN $32.48
  • 52 Week High
  • TMDX $177.37
  • LIVN $64.48
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 78.52
  • LIVN 70.16
  • Support Level
  • TMDX $92.49
  • LIVN $35.00
  • Resistance Level
  • TMDX $95.71
  • LIVN $37.95
  • Average True Range (ATR)
  • TMDX 4.79
  • LIVN 1.30
  • MACD
  • TMDX 0.81
  • LIVN 1.06
  • Stochastic Oscillator
  • TMDX 71.36
  • LIVN 91.36

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About LIVN LivaNova PLC

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: